Drug Information

Drug General Information
Drug ID
D04VZS
Former ID
DCL000097
Drug Name
CTS-21166
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 1 [522234]
Company
CoMentis
Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [525343]
References
Ref 522234ClinicalTrials.gov (NCT00621010) Safety Study of CTS21166 to Treat Alzheimer Disease. U.S. National Institutes of Health.
Ref 525343ClinicalTrials.gov (NCT00621010) Safety Study of CTS21166 to Treat Alzheimer Disease. U. S. National Institutes of Health. 2008.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.